ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Field of Research : Oncology And Carcinogenesis
Research Topic : Extracellular Matrix
Status : Closed
Clear All
Filter by Field of Research
Oncology And Carcinogenesis (6)
Biochemistry and Cell Biology (2)
Cellular Interactions (Incl. Adhesion, Matrix, Cell Wall) (2)
Biochemistry And Cell Biology Not Elsewhere Classified (1)
Reproduction (1)
Filter by Socio-Economic Objective
Cancer and related disorders (2)
Biological sciences (1)
Digestive system and disorders (1)
Reproductive system and disorders (1)
Treatments (e.g. chemicals, antibiotics) (1)
Filter by Funding Provider
National Health and Medical Research Council (4)
Australian Research Council (2)
Filter by Status
Closed (6)
Filter by Scheme
NHMRC Project Grants (3)
ARC Future Fellowships (1)
Discovery Projects (1)
NHMRC Postgraduate Scholarships (1)
Filter by Country
Australia (2)
Filter by Australian State/Territory
SA (1)
VIC (1)
  • Researchers (2)
  • Funded Activities (6)
  • Organisations (13)
  • Funded Activity

    Mechanism Of Breast Cancer Metastasis: Tumour Cell Remodelling Of The Extracellular Matrix

    Funder
    National Health and Medical Research Council
    Funding Amount
    $377,331.00
    Summary
    The main complication in breast cancers leading to death is metastatic relapse. This research aims to understand the role for a protease that promotes spread of breast cancer to the lymph nodes and lungs. The outcomes will identify a novel process that leads to lymph node metastasis and offer a new target for therapies that prevent relapse and tests to identify breast cancer patients at risk of relapse.
    More information
    Funded Activity

    MMP-13 As A Therapeutic Target In Breast Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $537,579.00
    Summary
    MMP13 is upregulated in cancer cells and in the tissue that forms around the cancer (stroma). A new MMP13-specific inhibitor reduces breast cancer growth in a mouse model, both at the primary site and also in bone. We will determine the role of MMP13 made by the cancer cells and stroma, respectively, extend the inhibitor work, and identify proteins being cleaved by MMP13. Being a late-stage manifestation, bone metastasis may represent an important clinical trial setting for MMP inhibitors.
    More information
    Funded Activity

    Role Of A Novel Tks5-Nck Signaling Pathway In Cancer Invasion

    Funder
    National Health and Medical Research Council
    Funding Amount
    $560,434.00
    Summary
    Invasion and metastasis are major causes of death in cancer patients. Our research has uncovered a pathway that increases the invasive potential of tumour cells in vitro. We now aim to determine if the pathway is relevant in invasion and metastasis in clinically relevant models; how a drug targeting the pathway affects invasion and; the extent to which the pathway is active in human tumours. These studies may identify a new molecular target for anti-invasive drugs.
    More information
    Funded Activity

    The Role Of The Human RECK Protein In Modifying Human Sarcoma Progression Within In Vitro And In Vivo Models

    Funder
    National Health and Medical Research Council
    Funding Amount
    $34,878.00
    Summary
    The protein “RECK” is known to have a controlling effect on cancers by reducing growth, invasion, and blood supply. RECK is present in normal tissues but in bone and soft-tissue tumours (sarcomas), the protein is reduced. This study aims to; correlate RECK levels in sarcoma with patient survival, use gene technology to increase RECK levels in sarcoma cells, and observe the effects on sarcoma invasion and metastasis.
    More information
    Funded Activity

    ARC Future Fellowships - Grant ID: FT0990785

    Funder
    Australian Research Council
    Funding Amount
    $686,400.00
    Summary
    Regulation of tissue morphogenesis in reproductive function and metastatic cancer. Infertility, endocrine and metabolic disorders and reproductive cancers are all increasing medical problems and principal contributors to morbidity and mortality in the Australian community. This research takes the novel approach of investigating the mechanisms of dynamic remodeling in reproductive organs. Novel hormonally controlled mechanisms of tissue remodeling unique to reproductive organs and cancers in ad .... Regulation of tissue morphogenesis in reproductive function and metastatic cancer. Infertility, endocrine and metabolic disorders and reproductive cancers are all increasing medical problems and principal contributors to morbidity and mortality in the Australian community. This research takes the novel approach of investigating the mechanisms of dynamic remodeling in reproductive organs. Novel hormonally controlled mechanisms of tissue remodeling unique to reproductive organs and cancers in adults have been discovered. The results are being applied to new medical alternatives for infertile patients and new diagnostics and therapeutics for patients with metastatic cancers. The information is also being applied to improve reproductive efficiency in animal production industries.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP0878303

    Funder
    Australian Research Council
    Funding Amount
    $234,000.00
    Summary
    The role of retinoic acid signalling in the development of the oesophageal epithelium. Oesophageal adenocarcinoma (OAC) is a disease with increasing incidence. The majority of patients with OAC are diagnosed when the cancer is at a late stage and therefore treatment options are limited, meaning the disease is almost invariably fatal. OAC arises from the precancerous condition, Barrett's oesophagus, which occurs as a consequence of chronic reflux, although the key processes driving its developmen .... The role of retinoic acid signalling in the development of the oesophageal epithelium. Oesophageal adenocarcinoma (OAC) is a disease with increasing incidence. The majority of patients with OAC are diagnosed when the cancer is at a late stage and therefore treatment options are limited, meaning the disease is almost invariably fatal. OAC arises from the precancerous condition, Barrett's oesophagus, which occurs as a consequence of chronic reflux, although the key processes driving its development are unknown. This project aims to better understand the critical first step in the progression to cancer and thus expand the scope for the development of therapies, particularly those aimed at early intervention, and tools that predict progression.
    Read more Read less
    More information

    Showing 1-6 of 6 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback